People · Operator
Named in public records as an officer, director or promoter · active 2008–2024 · Biotechnology, Other Technology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vaxart, Inc. | — | Biotechnology | Series B | $40.4M | $793.8M | 2009 |
| seqWell Inc. | — | Other Technology | Series A | $22.5M | $15.8M | 2017 |
| WaveMark Inc | — | Other Health Care | Series A | $18.9M | $56.9M | 2008 |
| S2 Genomics, Inc. | — | Biotechnology | Seed | $4.4M | $64.6M | 2021 |
| PharmaSecure, Inc. | — | Other Technology | Seed | $4.4M | $18.8M | 2009 |
| Innerscope Research, Inc. | — | Other | Seed | $3.5M | $18.6M | 2009 |
Michael Finney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Finney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PETER WAGNER | 1 | 11 |
| Brian Levine | 1 | 7 |
| Chad Souvignier | 1 | 4 |
| Michael Wiley | 1 | 4 |
| David Madden | 1 | 3 |
| Richard Markham | 1 | 3 |
| Paul McEwan | 1 | 3 |
| Michael J. Finney | 1 | 3 |
| Stevan Jovanovich | 1 | 2 |
| David Liebowitz | 1 | 2 |
| Dan Calvo | 1 | 2 |
| William McKenzie | 1 | 2 |
| Rob Wilson | 1 | 2 |
| Thomas Grant | 1 | 2 |
| Prafull Sheth | 1 | 1 |
| Robert J. Molinari | 1 | 1 |
| Sean Tucker | 1 | 1 |
| Nathan J. Sigworth | 1 | 1 |
| Daniel Calvo | 1 | 1 |
| N. Taylor Thompson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.